Featured Research

from universities, journals, and other organizations

Renal cancer cells thrive when put in right environment, supported by specific enzyme

Date:
April 6, 2014
Source:
Fox Chase Cancer Center
Summary:
Tumor cells are picky about where they live. In the wrong environment, they fail to reach their potential. But put those same cells on the right bit of real estate, and they grow like mad. Researchers found renal cancer cells planted in a supportive environment proliferate with the help of an enzyme usually only seen in the brain.

Tumor cells are picky about where they live. In the wrong environment, they fail to reach their potential. But put those same cells on the right bit of real estate, and they grow like mad. Researchers at Fox Chase Cancer Center found renal cancer cells planted in a supportive environment proliferate with the help of an enzyme usually only seen in the brain.

Related Articles


The enzyme, a specific isoform of a rather common kinase, may eventually become a target for cancer therapy as kinases constitute reasonably targetable enzymes, said Edna Cukierman, PhD, Associate Professor at Fox Chase, whose research focuses on the interactions between tumors and the microenvironments where they live. The research will be presented on April 6 at the AACR Annual Meeting 2014.

The microenvironment that Cukierman uses to help determine a cancer's fate is called the extracellular matrix (ECM), a network of structural molecules localized outside the cell that play a role in regulating numerous cell behaviors, for instance known by sending signals to promote wound healing or embryonic growth and development. Cukierman employs a three-dimensional model she developed to watch what happens when a tumor-altered matrix encourages cancer growth.

In cooperation with surgeons at Fox Chase, Cukierman uses freshly donated renal cell carcinoma tissue and extracts cells called fibroblasts from kidney tissue well outside of the tumor growth margins. She collects other fibroblasts from tissue within the cancer growth area of the same patient. The fibroblasts, which naturally secrete the mesenchymal extra cellular matrix, are used to create two sets of three-dimensional scaffolding per patient, one matrix from pro-growth fibroblast and a second from fibroblasts that keep tumor growth under control.

The researchers put renal cancer cells from established cell lines into both matrices. Those put in the tumor-promoting matrix proliferated quickly, with rapid metabolism and invasive capabilities. Identical cancer cells put in the normal matrix from the same patient grew slowly, failed to invade and when researchers withdrew external nutrients, the cells died. After the cancer cells were allowed to grow, the researchers looked at how the protein composition of the proliferating cancer cells differed from the lazy cancer cells by performing an RNA expression analysis. The analysis revealed that cancer cells in the pro-growth matrix had higher levels of RNA for a kinase normally found in neurons in the brain. A kinase is an enzyme capable of attaching phosphate groups to other molecules and many kinases constitute excellent targets used in cancer treatments.

When researchers inhibited the kinase, cancer cell division and spread halted, suggesting that the kinase was not just a cancer marker, but played an important role in cancer growth.

"So we were able to validate that this interesting kinase, which has no business being in the kidney, is functionally responsible for responding to cues that the matrix is transmitting," Cukierman said. When her team examined the tumors of the patients who donated the fibroblasts, they found elevated levels of the same kinase isoform.

"This is really exciting because we know that we may be able to try, at some distant point in the future, ways to inhibit this enzyme. There's a good chance it will be rather specific to cancer. And since this kinase is otherwise found merely in the brain, we would try to make a drug that didn't cross the blood-brain barrier and create too many side effects," she said.

Further, she hopes that similar approaches could help her find the key to converting tumor-promoting matrix into a tumor-confining substrate. "But right now, we're just looking at the matrix-induced tumoral mechanisms, and trying to understand how come this enzyme is up-regulated in cancer cells that are in the tumor-associated but not in the normal microenvironment."


Story Source:

The above story is based on materials provided by Fox Chase Cancer Center. Note: Materials may be edited for content and length.


Cite This Page:

Fox Chase Cancer Center. "Renal cancer cells thrive when put in right environment, supported by specific enzyme." ScienceDaily. ScienceDaily, 6 April 2014. <www.sciencedaily.com/releases/2014/04/140406162457.htm>.
Fox Chase Cancer Center. (2014, April 6). Renal cancer cells thrive when put in right environment, supported by specific enzyme. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2014/04/140406162457.htm
Fox Chase Cancer Center. "Renal cancer cells thrive when put in right environment, supported by specific enzyme." ScienceDaily. www.sciencedaily.com/releases/2014/04/140406162457.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins